A carregar...
Metformin Targets Foxo1 to Control Glucose Homeostasis
Metformin is the first-line pharmacotherapy for type 2 diabetes mellitus (T2D). Metformin exerts its glucose-lowering effect primarily through decreasing hepatic glucose production (HGP). However, the precise molecular mechanisms of metformin remain unclear due to supra-pharmacological concentration...
Na minha lista:
| Publicado no: | Biomolecules |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8231152/ https://ncbi.nlm.nih.gov/pubmed/34208360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom11060873 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|